| Literature DB >> 36188974 |
Adeel Ali Memon1, Corina Catiul1, Zachary Irwin2, Jennifer Pilkington1, Raima A Memon3, Allen Joop1, Kimberly H Wood1,4, Gary Cutter5, Marcas Bamman6,7, Svjetlana Miocinovic8, Amy W Amara1,6.
Abstract
Background: In a randomized, controlled trial, we showed that high-intensity rehabilitation, combining resistance training and body-weight interval training, improves sleep efficiency in Parkinson's disease (PD). Quantitative sleep EEG (sleep qEEG) features, including sleep spindles, are altered in aging and in neurodegenerative disease. Objective: The objective of this post-hoc analysis was to determine the effects of exercise, in comparison to a sleep hygiene, no-exercise control group, on the quantitative characteristics of sleep spindle morphology in PD.Entities:
Keywords: Parkinson’s disease; cognition; exercise; sleep; sleep spindles
Year: 2022 PMID: 36188974 PMCID: PMC9397800 DOI: 10.3389/fresc.2022.952289
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Figure 1Consort flow diagram.
Demographics and clinical characteristics.
| Characteristics | Exercise group | Sleep hygiene group |
| |
|---|---|---|---|---|
|
| 24 | 26 | ||
| Age (years) | ||||
| Mean ± SD | 65.7 ± 8.3 | 66.2 ± 5.1 | 0.28 | 0.78 |
| Range | 45–78 | 54–77 | ||
| Sex: | ||||
| Male | 14 (58.3) | 19 (73.1) | 1.21 | 0.27 |
| Female | 10 (41.7) | 7 (26.9) | ||
| Race: | ||||
| Caucasian | 22 (91.7) | 25 (96.2) | 0.45 | 0.5 |
| African American | 2 (8.3) | 1 (3.9) | ||
| Medications that affect sleep | 8 (33.3) | 7 (28.0) | 0.164 | 0.69 |
| Duration of Disease (DOD) (years) | ||||
| Median (IQR) | 6.0 (2.3–8.0) | 3.5 (1.0–8.0) | 1 | 0.31 |
| Levodopa Equivalent Dose (LED) | ||||
| Median (IQR) | 620.0 (410.0–843.8) | 545.0 (285.0–823.8) | 0.58 | 0.56 |
| MDS-UPDRS | ||||
| Part I | ||||
| Median (IQR) | 7.0 (4.3–10.5) | 9.0 (6.0–13.0) | −1 | 0.11 |
| Part II | ||||
| Mean ± SD | 10.8 ± 5.5 | 9.5 ± 5.2 | −0.85 | 0.4 |
| Range | 0–24 | 1–23 | ||
| Part III | ||||
| Mean + SD | 34.1 ± 12.9 | 29.0 ± 15.2 | −1.28 | 0.21 |
| Range | 10–70 | 4–65 | ||
| Part IV | ||||
| Median (IQR) | 3.0 (0.3–5.0) | 3.0 (0.0–6.0) | 0.18 | 0.86 |
| Total | ||||
| Mean + SD | 56.5 ± 18.2 | 51.6 ± 20.9 | −0.88 | 0.38 |
| Range | 30–105 | 17–97 | ||
Mean ± SD reported for normally distributed data. Median (IQR) reported for non-normally distributed data. MDS-UPDRS: Movement Disorders Society-Unified Parkinson's Disease Rating Scale.
Medications that affect sleep include benzodiazepines; non-benzodiazepine sedative hypnotics; narcotics; anti-psychotics; alpha-2 delta calcium channel ligands (gabapentin/pregabalin; melatonin; trazodone; oxybutynin; barbiturates.
Figure 2Exercise prevented the decrease in spindle density experienced during the first half of sleep by the sleep hygiene group (B). No significant changes in spindle density for the full night (A) and the second half of the sleep (C). In all panels, the figures are scatter plots, and error bars represent the mean and standard error of mean. ns: not significant.
Figure 3Spindle amplitude was not different between the two groups throughout the night (A), the first half of the sleep (B), or the second half of the sleep (C). In all panels, the figures are scatter plots, and error bars represent the mean and standard error of mean. ns: not significant.
Figure 4Exercise-induced changes in spindle density during the first half of the night are significantly correlated with changes in the memory domain scores (A). No significant correlations were found in the sleep hygiene group (B).